F-star Therapeutics
€0.000000
0
+€0.00+0% 00:00 Today
Statistics
Day High
-
Day Low
-
52W High
-
52W Low
-
Volume
-
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-
People Also Follow
This list is based on the watchlists of people on Stock Events who follow S4BA.MU. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
About
F-star Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops tetravalent bispecific antibodies for cancer therapy. Its medicines are used in immuno-oncology treatments. The company's principal product candidate is FS118 and is being evaluated in a proof-of-concept Phase 2 trial in PD-1/PD-L1 acquired resistance head and neck cancer patients. It is also developing first-in-human clinical study of FS222, a bispecific antibody that is in Phase 1 clinical trial targeting the costimulatory CD137 receptor and the inhibitory PD-L1 ligand. In addition, the company is also evaluating FS120 and SB 11285 for patients with advanced cancers, which are under Phase 1 clinical trials. F-star Therapeutics, Inc. was incorporated in 2002 and is headquartered in Cambridge, the United Kingdom.
Show more...
CEO
Employees
84
Country
United States
ISIN
US30315R1077
Listings
0 Comments
Share your thoughts
FAQ
What is F-star Therapeutics stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Boerse Muenchen exchange F-star Therapeutics stocks are traded under the ticker S4BA.MU.
How many employees does F-star Therapeutics have?▼
As of July 10, 2026, the company has 84 employees.
In which sector is F-star Therapeutics located?▼
F-star Therapeutics operates in the Manufacturing sector.
When did F-star Therapeutics complete a stock split?▼
F-star Therapeutics has not had any recent stock splits.
Where is F-star Therapeutics headquartered?▼
F-star Therapeutics is headquartered in Hopkinton, United States.